These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 16298558

  • 1. Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.
    Humphrey EL, Williams JH, Davie MW, Marshall MJ.
    Bone; 2006 May; 38(5):652-61. PubMed ID: 16298558
    [Abstract] [Full Text] [Related]

  • 2. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells.
    Hofbauer LC, Shui C, Riggs BL, Dunstan CR, Spelsberg TC, O'Brien T, Khosla S.
    Biochem Biophys Res Commun; 2001 Jan 12; 280(1):334-9. PubMed ID: 11162519
    [Abstract] [Full Text] [Related]

  • 3. Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL.
    Bord S, Frith E, Ireland DC, Scott MA, Craig JI, Compston JE.
    Bone; 2005 May 12; 36(5):812-9. PubMed ID: 15794927
    [Abstract] [Full Text] [Related]

  • 4. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.
    Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, Sakai H.
    Biochem Biophys Res Commun; 2000 Sep 07; 275(3):768-75. PubMed ID: 10973797
    [Abstract] [Full Text] [Related]

  • 5. Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells.
    Saunders MM, Taylor AF, Du C, Zhou Z, Pellegrini VD, Donahue HJ.
    J Biomech; 2006 Sep 07; 39(8):1419-27. PubMed ID: 15953606
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
    Wada N, Maeda H, Yoshimine Y, Akamine A.
    Bone; 2004 Sep 07; 35(3):629-35. PubMed ID: 15336598
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.
    Viereck V, Gründker C, Blaschke S, Frosch KH, Schoppet M, Emons G, Hofbauer LC.
    J Cell Biochem; 2005 Dec 15; 96(6):1244-53. PubMed ID: 16152630
    [Abstract] [Full Text] [Related]

  • 13. Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen.
    Bord S, Frith E, Ireland DC, Scott MA, Craig JI, Compston JE.
    Br J Haematol; 2004 Jul 15; 126(2):244-51. PubMed ID: 15238146
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.
    Shipman CM, Croucher PI.
    Cancer Res; 2003 Mar 01; 63(5):912-6. PubMed ID: 12615702
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.